EDIT Message Board Post 9191036 | Editas Medicine Inc.
home / stock / edit / edit message board
pERRY1234
(investorshub)
Posted on: Oct/16/2020 17:52:28
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158947526
Data at SITC. The poster is: Preclinical Development
News, Short Squeeze, Breakout and More Instantly...
-
All patients treated in the RUBY trial are free of vaso-occlusive events post- renizgamglogene autogedtemcel (reni-cel) infusion Patients had early normalization of total hemoglobin with a mean within the normal range at >14 g/dL and rapid and sustained improvements in fetal ...
-
All patients treated in the EdiTHAL trial maintained hemoglobin levels above the transfusion threshold and are transfusion-free post- renizgamglogene autogedtemcel (reni-cel) infusion Reni-cel was well-tolerated and demonstrated a safety profile consistent with myeloablative con...